ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

Completed

Phase 4 Results N/A

Summary of Purpose

The objective of ESPRIT was to compare the efficacy and safety of mild anticoagulation or a combination treatment of aspirin and dipyridamole with the efficacy and safety of treatment with aspirin alone after cerebral ischemia of arterial origin.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 March 2007.

1 Jul 1997 8 Sep 2005 Unavailable 1 Dec 2006 1 Mar 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available